A new method, employing the mild oxidant N-bromosuccinimide, for the iodination of proteins for radioimmunoassay is described. Human prolactin, follicle-stimulating, luteinising, thyroid-stimulating, and growth hormones were iodinated with 126 1 by this method to specific activities up to 136 !LCi/!Lg. Incorporation of iodine ranged from 67 %to 83 %using 2!Lg hormone, 200 !LCi Na 126I, O·5 nmol oxidant, and a reaction time of 15s. In comparative studies, the immunological activity after iodination by this method was equal to, or greater than, that by the chlorine gas, Iodo-Gen, or chloramine-T methods. The reagent is cheap and stable, and the method permits efficient use of antigen and iodide.
Although non-radioactively labelled protein ligands may be used in competitive binding assays, radioiodination is generally the most effective and widely used labelling technique.
Radioactive iodine is usually incorporated into a tyrosine group of the target protein by electrophilic substitution of a hydrogen atom in its aromatic ring. The stoichiometry of the reaction is: stimulating (FSH), luteinising (LH), thyroidstimulating (TSH), and growth (HGH) hormones prepared by this method were compared with those prepared using various modifications of the Iodo-Gen," chloramine-T1, and chlorine gas" methods.
Material and methods CHEMICALS These were Analar grade except N-brornosuceinimide, DL-tyrosine, and chloramine-T (all British Drug Houses, Poole, UK), which were reagent grade. Iodo-Gen was from Pierce & Warriner (UK) Ltd, Chester, UK. Sodium iodide-125 (IMS30, 100 rnCi/ml from Amersham International Ltd) was diluted on receipt with 1· 5 volumes of O'5M sodium phosphate buffer (pH 7· 5) to give a solution approximately 20 !LM in 126 1-. Bovine y-globulins (Cohn Fraction II) and bovine serum albumin (BSA) (crystallised lyophilised globulin-free powder) were from Sigma Ltd, Poole, UK. All solutions were prepared with glass-distilled water. 126 1+ + B-Tyr-Protein-s-P'j-Tyr-Protein + H+ To effect this reaction several electron acceptors (oxidants) have been used, for example, chloramine-T1, sodium hypochlorite," chlorine gas," iodine monochloride.s 1,3,4,6-tetracWoro-3 Ct, 6 e-diphenyl glycoluril (Iodo-Genj.s " and hydrogen peroxide. 7 An electrolytic method" has also been described (for review),"
When small quantities of proteins (2-5 !Lg) are labelled to the specific activities required for sensitive assays, considerable excesses of oxidant are usually needed, the amount varying with the reagent, the HORMONES species of proteinj' 10 and the reaction time.
FSH, LH, TSH, and prolactin were extracted and To reduce iodination damage it is desirable to purified from acetone-preserved human pituitary minimise the exposure of the protein to oxidising and glands in this laboratory. Their immunological strong reducing agents.l! A method is described in potencies were as follows; FSH 2300 U /mg (MRC which the mild oxidising agent, N-bromosuccinimide, 69/104), LH 6000 U/mg (MRC 68/40), TSH 6·0 is used to radioiodinate tyrosine-containing proteins IU/mg (MRC 68/38), and prolactin 23·0 U/mg to high specific activities with minimal exposure to (MRC75/704). HGH was thelyophilised preparation oxidising or reducing conditions. The immuno-MRC 69/46. The glycoprotein hormones were reactivities of iodinated human prolactin, follicle-stored (-20°C) at 200 mg/l in O'OlM sodium 129 phosphate buffer (pH 7'2) containing 0'2M sodium chloride. Prolactin was stored (-20 D C) as the lyophilised solid with sucrose (lmg/20ILg prolactin) carrier and reconstituted to make a 200 mg/l protein solution with O'OIM sodium bicarbonate. This solution could be stored for several months at -20 DC without loss of immunological activity. The HGH preparation was reconstituted to a nominal 200 mg/l with 0'05M sodium phosphate buffer (pH 7· 5) and stored at -70 DC. The protein concentrations of the other hormones were estimated on the assumption that a I gil solution has an absorbance at 280 nm of I' 0 in a I ern cell. Frozen samples (10 ILl) of these solutions were used immediately after thawing for iodination.
IODINATIONS
These were performed at room temperature in polystyrene, polypropylene, or glass vessels. In comparative studies, iodinations were performed in random order within 24 hours of each other using the same batch of hormone and iodide. Calculations of specific activity and recovery of iodinated hormone were as in Bolton," N -BROMOS UCCINIMIDE METHOD A sample (5 or 10 ILl) of Na l 251 solution (40 mCi/ml) was pipetted into the reaction vessel, 10 ILl of hormone (2 ILg) solution was added, and the reaction was started by the addition of 5 ILl of the appropriate dilution of a freshly prepared O'OIM solution of N-bromosuccinimide in water (the dilutions were typically 50-, 100-, or 2oo-fold). The mixture was quickly and briefly agitated on a vortex mixer, and IS seconds after adding the oxidant, 20 ILl of KI/ tyrosine solution (both I mrnol/l in 0'05M sodium phosphate buffer at pH 7· 5) and 2 ml of diluent (O'OIM sodium phosphate buffer containing 5 g/l BSA, 9 gil sodium chloride, O'OlM EDTA, and 100 mg/l thiomersal, final pH 7· 5) were added quickly in sequence. After counting, the mixture and washings were applied to Sephadex G-25 (21 x I· 5 ern) or G-100 (70 x I· 6 ern) columns and eluted with the same diluent to separate 'free' from proteinbound iodine.
In the immunological studies, O' 5 nmol of Nbromosuccinimide were used with 200 ILCi (for prolactin, FSH, LH, and TSH) or 400 ILCi (for HGH) of Na l 25 I. Reay the appropriate pH) containing Na 1251 (3000 cpm/ul), sufficient for monitoring but insufficient to interfere with assays, was used.
In preliminary experiments with N-bromosuccinimide, the method described above was used with BSA (200 mg/l in water) replacing hormone. In the pH studies the reactions were stopped by adding 0'1 rn1 of sodium metabisulphite solution (1'25 g/I in 0'5M sodium phosphate buffer, pH 7'5), and protein-bound iodine was isolated by precipitation with trichloroacetic acid (TCA-IO% w/v) in the presence of carrier BSA. In studies on methods of stopping the reactions, target BSA was omitted and protein-bound iodine was separated by precipitation with TCA or by chromatography on Sephadex G-25 as described above.
Prolactin (2 ILg) was iodinated (pH 7'5) in glass tubes by N-bromosuccinimide, chlorarnine-T'P and modified Iodo-Gen" methods, the reaction conditions being shown in Table I . Separation of 'free' from protein-bound iodine was by chromatography on Sephadex G-25.
RADIOIMMUNOASSAY TECHNIQUES
In comparative studies, each hormone, labelled by different methods, was tested in the same assay, and all the assays were performed throughout at room temperature.
Antiserum titrations
Labelled hormone (15 000 cpm) was incubated overnight with appropriate dilutions of antiserum in volumes of 1·0 ml (prolactin and HGH) or O'3 rn1 (FSH, LH, and TSH). Antibody-bound label was separated from free by precipitation with polyethylene glycol 6OOQl2 for HGH, and by an ammonium sulphate accelerated second antibody technique'" for the glycoproteins. For prolactin, antibody-bound hormone was precipitated by incubation for I hour with ammonium acetate/ ethanol (final concentrations 66 gil and 600 ml/l, respectively), a method developed in this laboratory. Normal rabbit serum (0'1 ml/tube) and bovine y-globulins (l mg/tube) were used as co-precipitants in the titrations of HGH and prolactin, respectively. Blanks without specific antibody were included, and the results were calculated from the mean of duplicate determinations 
Radioimmunoassays (for prolactin)
Sample and standard were preincubated with antiserum for 2 hours, label (15000 cpm) was added, and after incubation overnight antibody-bound hormone was separated as described above. Each sample was assayed in duplicate at five points on the standard curve.
Results

PRELIMINAR Y INVESTIGA TlONS
The optimum pH for the 127I-iodination of BSA with N-bromosuccinimide was 7'5, although almost as much incorporation occurred at pH 8·5 and 9'0 ( Table 2) . At pH 7·5 no further incorporation of iodine occurred after 15 seconds of addition of oxidant. When KI/tyrosine followed by carrier diluent was used to stop the reactions of iodination mixtures from which BSA has been omitted, less non-specific precipitation (8' 7 %) of iodine with TCA occurred than when sodium metabisulphite (20 fLI of 1·25 g/I) was used (10' 7 %), and no protein-bound iodine was detectable on chromatography of the mixture on Sephadex G-25.
N-BROMOS UCCINIMIDE IODINATIONS
Each of the hormones studied could be labelled by this method to specific activities suitable for radioimmunoassay (Table 3) . For FSH, HGH, and prolactin, the molar incorporation was more closely related to the amount of oxidant than to the amount of iodide used. The specific activities (61,64,63,64, and 65 fLCi/fLg) of five successive prolactin labels prepared at approximately monthly intervals for use in routine radioimmunoassays, using O·5 nmol N-bromosuccinimide and different batches of Na 125I, provide evidence of the controlled and repeatable nature of this method.
The mean (± SD) recoveries of 125I-labelled hormones from the Sephadex G-25 columns were 62 ± 6% (n = 5) for HGH and 86 ± 8% (n = 18) for the other hormones. Absorption to the reaction vessels accounted for any losses, with an additional loss of HGH on the Sephadex column. Recoveries of routinely labelled HGH (chloramine-T method) and the other hormones (chlorine gas method) were 0·1  0·5  83  73  1·4  LH  0·1  0·25  52  49  0·8  0·1  0·5  73  62  1·1  TSH  0·2  0·25  41  96  1·3  0·1  0·25  77  88  1·3  0·1  0·5  78  85  1·3  HGH  0·2  0·5  12  29  0·3  0·1  0·5  68  66  0·7  0·2  1·0  68  136  1·5  Prolactin  0·2  0·5  33  65  0·8  0·1  0·5  67  63  0·7  0·2  1·0  61  129  1·5 '2118 tForO· 2 nmol (400 I1Ci)linalreactionvolume~25 ul and forO· I nmollinalrcaction volume~20111. tCalculated from the manufacturer's specifications ofmCi/l1g"'I and the moleculer weights: FSH 36000, LH 32000, TSH 28 000, HGH 22 500 and prolactin 23 000. 
• A: Chlorine gas; B: N-Bromosuccinimide; C: Chloramine-T. Alllabeis purified on Sephadex G-25. tReciprocal final dilutions ofantiscra were: FSH I·~x 105,LHandTSH 1·5 x 104,HGHS X 10 3 , and prolactin I X 104 *50 % of total activity added. 59 ± 10% (n = 6) and 79 ± 10% (n = 18), respectively.
Typical amounts of oxidant, ratios of oxidant to iodide, and reaction times for the various iodination methods listed in Table 4 demonstrate the higher efficiency of the N-bromosuccinimide method.
COMPARATIVE STUDIES ON IODINATED PRODUCTS
The 1261-labelled products of the new method were compared by antiserum titration with those of the chloramine-T method for prolactin and HGH and the chlorine gas method for the glycoprotein hormones. The new method compared favourably with the others for prolactin and the glycoproteins, while giving similar results to the chloramine-T method for HGH ( Table 5) .
Examination of the elution profiles on Sephadex G-IOO of the 125I-labelled prolactins indicated that there were similarities, but the proportion of aggregate was higher in that prepared by the chloramine-T method (20 %) than by the new method (10%).
Determinations by radioimmunoassay of the potencies of 1271-iodinated prolactin relative to that of untreated hormone were also used to compare the new method with chloramine-T and lodo-Gen methods. These potencies were 95 % for the new method and 83 % for the lodo-Gen method. An estimate of the potency in the chloramine-T method could not be calculated because of non-parallelism with dose-response curves.
Discussion
Sensitive radioimmunoassays require iodinated antigens with high specific activity and minimal damage to the protein structure. Exposure of antigens to oxidising and reducing agents and lengthy exposure to radioiodine'P 11 are potential causes of loss of immunological activity. The x-bromosuccinimide method has been shown to involve minimal exposure to these hazards, while enabling satisfactory incorporation of iodine into the protein.
Previous studies with the chlorine gas method have demonstrated that biological activity of FSH is preserved after iodination," and the Iodo-Gen method has been considered to be less damaging to the protein than most," although some evidence to the contrary has been presented.P The present studies have shown that the new method compares favourably with both of these. The quality of the iodinated prolactin produced by the new method was superior to that prepared by the chloramine-T method while the HGH labels were comparable. Preliminary results (HJ Sage, personal communication) of a larger comparative study on iodination methods suggest that FSH labels prepared by the new method compare favourably, in terms of binding to excess and dilute antibody (Bo) and in non-specific binding, to those prepared by a solid phase lactoperoxidase rnethod.l" The lactoperoxidase methods are generally considered to cause minimal damage to proteins.
The immunological potency determinations of 1271-iodinated prolactin indicate that x-bromosuccinimide caused little damage to this labile hormone. Studies on the effect of this method on the biological potency of this and other hormones for use in, for example, radioreceptor assays would be worth while.
The reagent iodinates histamine efficiently (R Morris, personal communication) and therefore may be useful in the iodination of proteins (eg, porcine parathyroid hormone) which lack tyrosine but contain histidine residues.
Why the reagent is more efficient in iodination than other sources of 'positive' halogen has not been investigated. However, preliminary results of my studies on N-chlorosuccinimide, which appears to be as efficient as the bromo-derivative for iodination and more effective on a molar basis than chlorine water or hypochlorite, suggest the involvement of the succinimidyl moiety in the iodination reactions.
The method is simple to perform and has given reproducible and controlled incorporation of iodine. The reagent is stable, cheap, and efficient in the use of Na l 26I and protein and should be useful for the iodination of many proteins.
I thank Professor WR Butt for help in the preparation of the manuscript, Dr SS Lynch for valuable technical advice, and Mr W Robinson for preparing the routinely labelled glycoprotein hormones.
